康寧醫院(02120.HK)2022年收入14.85億元 同比增加14.4%
格隆匯4月14日丨康寧醫院(02120.HK)公吿,截至2022年12月31日止年度,公司期間實現收入人民幣14.85億元,較2021年增加14.4%,其中自有醫院運營收入為人民幣13.67億元,較2021年增加13.6%。報吿期間,自有醫院毛利率為23.9%(2021年:25.4%),集團整體毛利增加至人民幣3.53億元,較2021年增加7.3%。
報吿期間,歸屬於公司股東的淨虧損為人民幣2420萬元,主要由於2022年存在部分對當年業績存在一次性影響的項目,扣除該等項目後歸屬於公司股東的淨利潤為人民幣4110萬元。報吿期間,集團經營活動產生的現金淨額為人民幣227.2百萬元(2021年:人民幣193.9百萬元),較2021年增長17.2%。
截至2022年12月31日,集團自有醫院增至29家(2021年12月31日:27家),其中包括1家獨立設置的互聯網醫院(怡寧心理互聯網醫院),運營牀位數增至9,688張(2021年12月31日:8,728張)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.